NOOTROPIL

This brand name is authorized in Brazil, Cyprus, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug NOOTROPIL contains one active pharmaceutical ingredient (API):

1	Piracetam UNII ZH516LNZ10 - PIRACETAM
	Piracetam’s mode of action in cortical myoclonus is as yet unknown. Piracetam exerts its haemorrheological effects on the platelets, red blood cells, and vessel walls by increasing erythrocyte deformability and by decreasing platelet aggregation, erythrocyte adhesion to vessel walls and capillary vasospasm.
	Read more about Piracetam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NOOTROPIL Film-coated tablet / Oral solution / Solution for injection	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06BX03	Piracetam	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BX Other psychostimulants and nootropics
Discover more medicines within N06BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576720090086917, 576720090087017
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	14325579
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1416-MEE-0915, 2442-MEE-1116
EE	Ravimiamet	1023343, 1074439, 1074440, 1813766, 1813777, 1813788, 1816444, 1826366, 1826377, 1826388, 1829347
ES	Centro de información online de medicamentos de la AEMPS	54713, 55917
FI	Lääkealan turvallisuus- ja kehittämiskeskus	004861
GB	Medicines & Healthcare Products Regulatory Agency	143745, 162142, 381565, 38934, 40926, 94824
HK	Department of Health Drug Office	24251, 36938
LT	Valstybinė vaistų kontrolės tarnyba	1010980, 1010981, 1068160, 1079686, 1079687, 1081560, 1081561, 1081562, 1085195, 1085196, 1086183, 1087912, 1087913, 1090096, 1090113, 1090114, 1090115, 1090116, 1090117, 1090402, 1090403, 1092289
MT	Medicines Authority	MA030/00503
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	036M85, 89175
NL	Z-Index G-Standaard, PRK	31186, 6548
PL	Rejestru Produktów Leczniczych	100048044, 100048050, 100048067, 100048073, 100088760, 100270995, 100299705, 100305216, 100306747, 100326460, 100326477, 100334710, 100339534, 100357621, 100361611, 100361657, 100385296, 100395159, 100420160, 100440300, 100450552, 100456300, 100456396, 100464994
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W57090001, W57090002, W57090003
SG	Health Sciences Authority	00574P, 01279P, 08988P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699624090010, 8699624570031, 8699624750013
ZA	Health Products Regulatory Authority	F/1.1/184, J/1.1/399